Vanderbilt Ingram Cancer Center

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read More

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season. Read More

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding. Read More

Maury Regional Medical Center (MRMC) and Vanderbilt-Ingram Cancer Center (VICC) have joined forces to open a new radiation oncology treatment center for cancer patients in Spring Hill, Tenn. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

On Tuesday, award-winning country music star Martina McBride and a group of her fans presented a check for $40,550 in support of cancer research at Vanderbilt-Ingram Cancer Center. Read More

The Vanderbilt Breast Center is piloting new measures to ensure continuity of care and timely insurance preauthorization as patients come off grant-sponsored clinical trial protocols and begin or resume standard care. Read More

Jordan Berlin, M.D., professor of Medicine and Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has received the Tree of Life award from Debbie’s Dream Foundation: Curing Stomach Cancer (DDF). Read More

(photo by Steve Green Steve Wolff, M.D., left, was honored at the VICC Stem Cell Transplant Survivors Reunion for his leadership in the development of the Vanderbilt Stem Cell Transplant Program in the early 1980s. John Greer, M.D., presented Wolff, a lifelong fan of the New York… Read More

The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center. Read More

Carlos Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to lead two newly created cancer research initiatives at the Vanderbilt-Ingram Cancer Center. Read More

An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus. Read More

Cancer patients, family members and cancer health care workers all have a story to tell. Those who want to share their stories through music are invited to enroll in a songwriting workshop for the upcoming May 17 Songs from the Heart Concert. The annual songwriting workshop and… Read More

Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, acting chair of Cancer Biology and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. Read More

The future of cancer is becoming clearer. And it’s not looking so good for cancer. Read More

Nobel laureate Lee Hartwell, Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, April 11. Read More

Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Read More

Harold L. (Hal) Moses, M.D., professor and acting chair of Cancer Biology and professor of Medicine and Pathology, Microbiology and Immunology, has been named to the first class of the Fellows of the American Association for Cancer Research (AACR) Academy. Read More

Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. Read More

Most cancers are sporadic, which means that physicians don’t have enough clues to determine what caused an individual’s disease. Read More